The U.S., U.K., and parts of Europe have been gripped with consumer fervour over CBD products, while Health Canada continues to treat CBD as a controlled substance. The result? Mat Columbro, co-founder of compliance consultants Vindica, noted the Ontario Cannabis Store stocks only two high-CBD flower products. However, Columbro noted the emergence of some low-priced CBD oils.
CSP Daily News, Twitter–@MatColumbro
- Growers were quick to say the problem is that CBD flower doesn’t sell–in part because provincial laws prevent REC stores from describing any medical effects, in part because many CBD consumers prefer to consume it in oil or capsule form.
Twitter–@Kieley_, @cannarelief420, @qnp
Consumers want high-THC cultivars they know will get them high. That’s created incentive for producers to shop around from lab to lab for the highest THC reading they can find, and engage in other skullduggery.
StratCann
Quick Hits
- This thread of suggestions for changes to the industry revealed no shortage of issues the sector has yet to deal with..
Twitter–@CannadaEd_